甲状腺毒性周期性 - - 来自印度南部的一项回顾性研究
Jinson Paul1, Aneez Joseph1, Felix Jebasingh1
1Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India.
European thyroid journal
|October 14, 2024
概括
甲状腺毒性周期性是一种罕见的疾病,与甲状腺毒性病患者的血清和甲状腺激素水平降低有关. 这项研究突出了印度患者的关键临床和生化差异.
科学领域:
- 内分泌学 在内分泌学.
- 神经学 神经学
背景情况:
- 甲状腺毒性周期性 (TPP) 是甲状腺毒性病的不常见但严重的并发症.
- 它呈现为急性松性的发作,主要影响亚裔男性.
- 了解其临床和生化特征对于及时诊断和管理至关重要.
研究的目的:
- 描述甲状腺毒性周期性的临床和生化特征.
- 为了评估印度患者队列中的治疗结果.
- 将TPP患者与没有的甲状腺毒性病患者进行比较.
主要方法:
- 在印度南部的一个三级护理中心进行的一项回顾性研究.
- 将TPP患者 (病例) 与甲状腺毒性但没有的患者 (对照组) 进行比较.
- 收集了关于临床表现,生化参数和接受治疗的数据.
主要成果:
- 该研究包括41例病例和对照,在TPP组中男性比例高 (92.6%).
- 与对照组相比,TPP患者的平均血清,自由T4,总T4和总T3水平显著降低.
- 格雷夫斯病是这两个组中甲状腺毒性病的主要原因;在TPP病例中,喉不那么常见.
结论:
- 这项研究代表了印度最大的TPP案例系列之一.
- 显着较低的血清和甲状腺激素水平被观察到在甲状腺毒性患者有周期性.
- 两个病例表明潜在的同时存在的吉特曼综合征有助于低血糖症.
更多相关视频
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
188
11:46Investigation of the Electrophysiological and Thermographic Safety Parameters of Surgical Energy Devices During Thyroid and Parathyroid Surgery in a Porcine Model
Published on: October 13, 2022
1.4K
相关概念视频
Myasthenia Gravis: Diagnostic Tests
686
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
686
Electroconvulsive Therapy
26
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
26
